Over 40, diets stopped working. The science finally caught up.
In the largest weight-loss trial ever published, the triple-agonist retatrutide averaged 24.2% body-weight loss in 48 weeks - more than Ozempic or Mounjaro, and built for how metabolism changes after 40.
24.2% - the most weight ever lost in a trial.
In a 48-week trial published in the New England Journal of Medicine (2023), adults on retatrutide lost an average of 24.2% of their body weight - around 26kg. It was the largest reduction ever reported for a weight-loss compound.
More weight lost, in less time. Individual results vary; trial figures are not a promise of personal outcome.
The transformations say it best.
Two people, in their own words - when the weight finally moved and stayed off.
It was never willpower. After 40, the rules changed.
Cut calories and your body fights back - metabolism drops, hunger hormones spike, and the weight creeps home. The old "eat less, move more" advice ignores all of it, which is why you can follow it perfectly and still fail.
After 40 it gets harder: you lose 3-8% of your muscle each decade, so your metabolism slows and the diet that worked at 30 does almost nothing. It just shows up differently for women and men.
Menopause moved the goalposts.
As estrogen falls, fat stops settling on your hips and packs around your middle as visceral fat, while insulin sensitivity drops - so it lands on your belly and won't shift.
Testosterone quietly slipped.
Falling testosterone means less muscle-building signal and more visceral fat around the organs - you train the same, eat the same, and still watch the gut grow.
A triple-agonist is the first tool built for exactly this. It doesn't ask you to out-diet your biology - it changes the signals driving it. Three metabolic switches, not one:
Silences the food noise
The same appetite pathway as Ozempic - hunger drops, cravings fade, the constant thinking about food goes quiet.
Fixes how you store fat
Improves insulin sensitivity and fat handling - the second lever Mounjaro added, and Ozempic never had.
Burns stored fat
The third switch, unique to retatrutide - it raises energy expenditure and drives your body to burn fat, not just eat less.
Why it leaves Ozempic and Mounjaro behind.
Same class of medicine - a completely different result, because of how many targets it actually hits.
BioStack Retatrutide 30mg
The triple-agonist, verified.
The exact compound the trial data is built on - from a lab that proves every batch.
The BioStack service standard
What every reader can expect when they message the lab, from the first hello to long after delivery.
Once your order is confirmed in chat, your peptides are dispatched from the factory within 2 minutes. No waiting days for someone to reply.
Reconstitution guidance, storage advice, tracking updates and help with anything that is not right when it arrives. The service does not stop when you pay.
24/7 live chat with real health professionals. The same team answers before your order and after it, any hour, any day.
Real results. A source you can verify.
"Nineteen kilos down and I still lift the same. The difference is I'm not thinking about food every waking minute anymore."
"I'd tried everything. First time the weight came off and stayed off - and the chat with their specialist made it feel safe."
Before you message us.
How is it different from Ozempic and Mounjaro?
How do I order?
Is it actually tested?
Is this medical advice?
The window is open. The choice is yours.
Stop fighting your own biology. Talk to a BioStack specialist, get the data, and start with the only triple-agonist - the smart way.
Talk to a Specialist Now 24/7 live chat · Talk to our health professionals anytime · Research use only